Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.53 (
sialidase
)
2,694
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against
epiglycanin
, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described. The specificities of 10 of the antibodies, with affinity constants in the range of 10(8)-10(10) l/mol were compared in an enzyme competitive binding assay. The affinity of
epiglycanin
was strongly reduced for all antibodies tested by incubation with periodate (10 mM, 4 degrees C) and was reduced for most of the antibodies by endo-alpha-N-acetyl- D-galactosaminidase. This suggested that carbohydrate, and specifically the Gal beta (1----3)GalNAc disaccharide, formed an integral part of the epitopes of most of the antibodies. The isolated disaccharide, however, exhibited 250,000 times less inhibitory activity in the competitive binding assay than
epiglycanin
. The binding capacity of
epiglycanin
was also reduced by incubation with trypsin or pronase, suggesting a high molecular weight dependency for binding. Incubation with
sialidase
increased its affinity for the antibodies. The binding of the antibodies to
epiglycanin
was strongly inhibited by peanut agglutinin, and to a lesser extent by lectins from Triticum vulgaris, Ricinus communis, Pisum sativum and Phaseolus vulgaris. None of the antibodies bound to any of eight different gangliosides immobilized on HPTLC plates. Mono- (Fab) and divalent [F(ab')2] fragments of the antibodies possessed very low affinity for
epiglycanin
. The results demonstrated that the specificities of the antibodies are related, but distinguishable, and they suggest that this
epiglycanin
-IgM model may be useful for studies on the general principles of the interaction between IgM antibodies and mucin-type glycoproteins.
...
PMID:Development and characterization of monoclonal antibodies against a mucin-type glycoprotein. 149 19